Models of care for hepatitis C in the era of directly acting antivirals

直接作用抗病毒药物时代丙型肝炎的护理模式

• 批准号: nhmrc : 1093846
• 负责人: Dr Amanda Wade
• 金额: $ 8.31万
• 依托单位: Macfarlane Burnet Institute for Medical Research and Public Health
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/models-care-hepatitis-acting-antivirals/519464
• 关键词: Models; care; hepatitis; era; directly

This project aims to evaluate how service delivery can enhance the impact of directly acting antivirals (DAA) on hepatitis C treatment uptake in three parts: i) To assess the impact of ten integrated hepatology nurses on treatment uptake in Victoria ii) To assess the feasibility of patient driven contact tracing to treat hepatitis C with DAA in a study of people who inject drugs iii) To assess the impact of offering DAA therapy in primary health care compared with a hospital.

该项目旨在评估服务提供如何增强直接作用抗病毒药物（DAA）对丙型肝炎治疗吸收的影响，分为三个部分：i）评估10名综合肝病科护士对维多利亚治疗吸收的影响ii）在注射毒品者研究中评估患者驱动的接触者追踪治疗丙型肝炎的可行性iii）评估与医院相比，在初级卫生保健中提供DAA治疗的影响。